Oncolytics Biotech,® Inc. (USA) (NASDAQ:ONCY) announced that it has submitted an application for Orphan Drug Designation to the U.
Oncolytics Biotech® Inc. (USA) (NASDAQ:ONCY) today announced that Dr.
Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European …
Canaccord Genuity analyst Neil Maruoka came out today with a research note on Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY), after the company released its fourth-quarter results, posting a net loss …
In a research report released today, Canaccord Genuity analyst Neil Maruoka reiterated a Buy rating on Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) with a C$2.
